The Vertiflex™ Procedure†

Superion™ Indirect Decompression System

Clinical Data

The Vertiflex Procedure is backed by one of the most extensive Level 1 Randomized Controlled Trials (RCT) in the industry that established long-term safety and effectiveness of the Superion Indirect Decompression System.1,2 The RCT outcomes are backed by real-world evidence from the Vertiflex Registry.3

Resources

Directions for Use Patient Resources Receive Pain Management Updates
Request a Sales Rep

Randomized Controlled Trial

The Vertiflex Procedure is supported by a 5-year Level 1 RCT that established our 6-7-8-9 clinical evidence:
66% BACK PAIN IMPROVEMENT1*. 75% LEG PAIN IMPROVEMENT1*
85% OPIOID REDUCTION2+. 90% PATIENT SATISFACTION1*

The outcomes were sustained over the 5-year study.

66% BACK PAIN IMPROVEMENT Chart.
75% LEG PAIN IMPROVEMENT Chart.
85% OPIOID REDUCTION Chart.
90% PATIENT SATISFACTION Chart.

The RCT demonstrated effectiveness for all types of moderate Lumbar Spinal Stenosis (LSS): Central, Lateral and Foraminal

LSS PATIENT TYPES Chart.
Spinal diagram.
     

Real-World Outcomes

The prospective Vertiflex Registry confirmed the high patient satisfaction from the RCT.
Patient Satisfaction by responder rate.
80% patient satisfaction on teal background.

80%
PATIENT
SATISFACTION§,3

Robust clinical evidence shows that Vertiflex is the Clear Choice for Moderate LSS

Top